Articles – Maculaser

New Clinical Trial Manager joins Maculaser

2024-06-11

We are pleased to announce that Aki Vartiainen joins the Maculaser team as Clinical Trial Manager.Aki brings strong expertise to our […]

2024-05-27

Maculaser has been granted a Japanese patent for its method and device for determining changes in retinal and/or brain temperature.

2024-03-26

Finnish new technology focused magazine T&T (Tekniikka ja Talous) reports on Maculaser’s goals and timeline in developing novel treatments for

2024-02-23

We are excited to announce that Kirsty Happonen joins the Maculaser team as Head of Regulatory Affairs and Quality Assurance. Kirsty

2024-01-05

We are seeking talented professionals to advance our mission of preventing blindness

2023-12-29

The paper discusses a new heat treatment for the retina that uses a special method, based on the bioelectrical response

2023-09-29

Maculaser has been awarded a 400kEUR Deep Tech Accelerator grant from Business Finland. This brings our total private and public funding

2023-07-12

Explore the Frontier of AMD Treatment Research: Mooud Amirkavei’s dissertation at Aalto University School of Science, defended on 2023-05-26, offers

2023-03-10

Maculaser, a company developing treatments for retinal disorders that affect millions of people worldwide and that currently have no effective